Directed new share issue in Neuroserach (DK) — DKK 84 million

Carnegie acted as joint book-runner in the directed new issue of 300.000 new shares. The new shares have been subscribed at a price of DKK 280 per share. NeuroSearch A/S is a Scandinavian biopharmaceutical company listed on the OMX Nordic Exchange Copenhagen A/S. May, 2008.